{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:44:06Z","timestamp":1793339046107,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Special Foundation for Science and Technology Basic Research Program","award":["2019FY101103"],"award-info":[{"award-number":["2019FY101103"]}]},{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81772170"],"award-info":[{"award-number":["81772170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Key Research and Development Program of China","award":["2017YFC0211700"],"award-info":[{"award-number":["2017YFC0211700"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12072-023-10512-1","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T15:43:34Z","timestamp":1680536614000},"page":"615-625","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characteristics and long-term mortality of patients with non-MAFLD hepatic steatosis"],"prefix":"10.1007","volume":"17","author":[{"given":"Hong","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"10512_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.12.002","author":"MH Le","year":"2019","unstructured":"Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, et al. Global NAFLD prevalence: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019. https:\/\/doi.org\/10.1016\/j.cgh.2021.12.002","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10512_CR2","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.cgh.2017.05.029","volume":"15","author":"ZM Younossi","year":"2017","unstructured":"Younossi ZM. Long-term outcomes of nonalcoholic fatty liver disease: from nonalcoholic steatohepatitis to nonalcoholic steatofibrosis. Clin Gastroenterol Hepatol. 2017;15(8):1144\u20131147. https:\/\/doi.org\/10.1016\/j.cgh.2017.05.029","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10512_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J Hepatol. 2018;69(4):896\u2013904. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.036","journal-title":"J Hepatol"},{"issue":"1","key":"10512_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","journal-title":"J Hepatol"},{"key":"10512_CR5","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2021.0310","author":"T Kawaguchi","year":"2021","unstructured":"Kawaguchi T, Tsutsumi T, Nakano D, Eslam M, George J, Torimura T. MAFLD enhances clinical practice for liver disease in the Asia-Pacific region. Clin Mol Hepatol. 2021. https:\/\/doi.org\/10.3350\/cmh.2021.0310","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"10512_CR6","doi-asserted-by":"publisher","first-page":"e745","DOI":"10.1210\/clinem\/dgab644","volume":"107","author":"X Wang","year":"2022","unstructured":"Wang X, Wu S, Yuan X, Chen S, Fu Q, Sun Y, et al. Metabolic dysfunction-associated fatty liver disease and mortality among chinese adults: a prospective cohort study. J Clin Endocrinol Metab. 2022;107(2):e745\u2013e755. https:\/\/doi.org\/10.1210\/clinem\/dgab644","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10512_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/hep.32131","volume":"75","author":"LA van Kleef","year":"2022","unstructured":"van Kleef LA, Ayada I, Alferink LJM, Pan Q, de Knegt RJ. Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: the Rotterdam study. Hepatology. 2022;75(2):419\u2013429. https:\/\/doi.org\/10.1002\/hep.32131","journal-title":"Hepatology"},{"key":"10512_CR8","doi-asserted-by":"publisher","first-page":"154433","DOI":"10.1016\/j.metabol.2020.154433","volume":"115","author":"DQ Sun","year":"2021","unstructured":"Sun DQ, Jin Y, Wang TY, Zheng KI, Rios RS, Zhang HY, et al. MAFLD and risk of CKD. Metabolism. 2021;115:154433. https:\/\/doi.org\/10.1016\/j.metabol.2020.154433","journal-title":"Metabolism"},{"issue":"11","key":"10512_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/hepr.13685","volume":"51","author":"T Tsutsumi","year":"2021","unstructured":"Tsutsumi T, Eslam M, Kawaguchi T, Yamamura S, Kawaguchi A, Nakano D, et al. MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach. Hepatol Res. 2021;51(11):1115\u20131128. https:\/\/doi.org\/10.1111\/hepr.13685","journal-title":"Hepatol Res"},{"issue":"12","key":"10512_CR10","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1111\/liv.14675","volume":"40","author":"S Yamamura","year":"2020","unstructured":"Yamamura S, Eslam M, Kawaguchi T, Tsutsumi T, Nakano D, Yoshinaga S, et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int. 2020;40(12):3018\u20133030. https:\/\/doi.org\/10.1111\/liv.14675","journal-title":"Liver Int"},{"key":"10512_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.12.035","author":"Y Fouad","year":"2021","unstructured":"Fouad Y, Gomaa A, Semida N, Ghany WA, Attia D. Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists. J Hepatol. 2021. https:\/\/doi.org\/10.1016\/j.jhep.2020.12.035","journal-title":"J Hepatol"},{"key":"10512_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-326992","author":"R Hernaez","year":"2022","unstructured":"Hernaez R, Peck-Radosavljevic M. MAFLD, HCC and the dilemma of (changing) terminology in liver diseases. Gut. 2022. https:\/\/doi.org\/10.1136\/gutjnl-2022-326992","journal-title":"Gut"},{"issue":"3","key":"10512_CR13","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/hep.31420","volume":"73","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Rinella ME, Sanyal AJ, Harrison SA, Brunt EM, Goodman Z, et al. From NAFLD to MAFLD: implications of a premature change in terminology. Hepatology. 2021;73(3):1194\u20131198. https:\/\/doi.org\/10.1002\/hep.31420","journal-title":"Hepatology"},{"issue":"12","key":"10512_CR14","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1016\/j.cgh.2021.02.015","volume":"19","author":"F Angelico","year":"2021","unstructured":"Angelico F, Pastori D, Del Ben M. Impact of the new metabolic-associated fatty liver disease (MAFLD) on NAFLD patients classification in Italy. Clin Gastroenterol Hepatol. 2021;19(12):2683\u20132684. https:\/\/doi.org\/10.1016\/j.cgh.2021.02.015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10512_CR15","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.cgh.2020.08.017","volume":"19","author":"D Kim","year":"2021","unstructured":"Kim D, Cholankeril G, Loomba R, Ahmed A. Prevalence of fatty liver disease and fibrosis detected by transient elastography in adults in the United States, 2017\u20132018. Clin Gastroenterol Hepatol. 2021;19(7):1499\u2013501.e2. https:\/\/doi.org\/10.1016\/j.cgh.2020.08.017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10512_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/s2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(8):739\u2013752. https:\/\/doi.org\/10.1016\/s2468-1253(20)30077-7","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10512_CR17","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. https:\/\/doi.org\/10.1371\/journal.pmed.1001779","journal-title":"PLoS Med"},{"issue":"4","key":"10512_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/geront\/34.4.486","volume":"34","author":"VL Burt","year":"1994","unstructured":"Burt VL, Harris T. The third national health and nutrition examination survey: contributing data on aging and health. Gerontologist. 1994;34(4):486\u2013490. https:\/\/doi.org\/10.1093\/geront\/34.4.486","journal-title":"Gerontologist"},{"key":"10512_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32499","author":"ZM Younossi","year":"2022","unstructured":"Younossi ZM, Paik JM, Al Shabeeb R, Golabi P, Younossi I, Henry L. Are there outcome differences between NAFLD and metabolic-associated fatty liver disease? Hepatology. 2022. https:\/\/doi.org\/10.1002\/hep.32499","journal-title":"Hepatology"},{"issue":"1","key":"10512_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","volume":"18","author":"N Tamaki","year":"2022","unstructured":"Tamaki N, Ajmera V, Loomba R. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat Rev Endocrinol. 2022;18(1):55\u201366. https:\/\/doi.org\/10.1038\/s41574-021-00584-0","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10512_CR21","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.cgh.2014.11.027","volume":"13","author":"SC Lin","year":"2015","unstructured":"Lin SC, Heba E, Wolfson T, Ang B, Gamst A, Han A, et al. Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique. Clin Gastroenterol Hepatol. 2015;13(7):1337\u201345.e6. https:\/\/doi.org\/10.1016\/j.cgh.2014.11.027","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10512_CR22","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2471\/blt.07.043497","volume":"85","author":"M de Onis","year":"2007","unstructured":"de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85(9):660\u2013667. https:\/\/doi.org\/10.2471\/blt.07.043497","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10512_CR23","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.26156","volume":"57","author":"D Kim","year":"2013","unstructured":"Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology. 2013;57(4):1357\u20131365. https:\/\/doi.org\/10.1002\/hep.26156","journal-title":"Hepatology"},{"key":"10512_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2021.07.009","author":"Z Liu","year":"2021","unstructured":"Liu Z, Suo C, Zhao R, Yuan H, Jin L, Zhang T, et al. Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease. Dig Liver Dis. 2021. https:\/\/doi.org\/10.1016\/j.dld.2021.07.009","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10512_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","volume":"17","author":"M Eslam","year":"2020","unstructured":"Eslam M, George J. Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology. Nat Rev Gastroenterol Hepatol. 2020;17(1):40\u201352. https:\/\/doi.org\/10.1038\/s41575-019-0212-0","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10512_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/hep.30996","volume":"72","author":"F Stickel","year":"2020","unstructured":"Stickel F, Lutz P, Buch S, Nischalke HD, Silva I, Rausch V, et al. Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers. Hepatology. 2020;72(1):88\u2013102. https:\/\/doi.org\/10.1002\/hep.30996","journal-title":"Hepatology"},{"issue":"12","key":"10512_CR27","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3417","volume":"47","author":"S Buch","year":"2015","unstructured":"Buch S, Stickel F, Tr\u00e9po E, Way M, Herrmann A, Nischalke HD, et al. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nat Genet. 2015;47(12):1443\u20131448. https:\/\/doi.org\/10.1038\/ng.3417","journal-title":"Nat Genet"},{"issue":"11","key":"10512_CR28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nrg3786","volume":"15","author":"JS Witte","year":"2014","unstructured":"Witte JS, Visscher PM, Wray NR. The contribution of genetic variants to disease depends on the ruler. Nat Rev Genet. 2014;15(11):765\u2013776. https:\/\/doi.org\/10.1038\/nrg3786","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10512_CR29","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jhep.2021.06.013","volume":"75","author":"X Chen","year":"2021","unstructured":"Chen X, Chen S, Pang J, Tang Y, Ling W. Are the different MAFLD subtypes based on the inclusion criteria correlated with all-cause mortality? J Hepatol. 2021;75(4):987\u2013989. https:\/\/doi.org\/10.1016\/j.jhep.2021.06.013","journal-title":"J Hepatol"},{"key":"10512_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.04.012","author":"H Park","year":"2022","unstructured":"Park H, Yoon EL, Kim M, Cho S, Nah EH, Jun DW. Nomenclature dilemma of metabolic associated fatty liver disease (MAFLD): considerable proportions of mafld are metabolic healthy. Clin Gastroenterol Hepatol. 2022. https:\/\/doi.org\/10.1016\/j.cgh.2022.04.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10512_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.10.046","author":"V Wai-Sun Wong","year":"2020","unstructured":"Wai-Sun Wong V, Lai-Hung Wong G, Woo J, Abrigo JM, Ka-Man Chan C, She-Ting Shu S, et al. Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the disease. Clin Gastroenterol Hepatol. 2020. https:\/\/doi.org\/10.1016\/j.cgh.2020.10.046","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10512_CR32","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.2147\/dmso.S316096","volume":"14","author":"J Huang","year":"2021","unstructured":"Huang J, Xue W, Wang M, Wu Y, Singh M, Zhu Y, et al. MAFLD Criteria may overlook a subtype of patient with steatohepatitis and significant fibrosis. Diabetes Metab Syndr Obes. 2021;14:3417\u20133425. https:\/\/doi.org\/10.2147\/dmso.S316096","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"10512_CR33","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jhep.2020.06.016","volume":"73","author":"J Huang","year":"2020","unstructured":"Huang J, Kumar R, Wang M, Zhu Y, Lin S. MAFLD criteria overlooks a number of patients with severe steatosis: is it clinically relevant? J Hepatol. 2020;73(5):1265\u20131267. https:\/\/doi.org\/10.1016\/j.jhep.2020.06.016","journal-title":"J Hepatol"},{"issue":"2","key":"10512_CR34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/gutjnl-2020-322564","volume":"71","author":"R Younes","year":"2022","unstructured":"Younes R, Govaere O, Petta S, Miele L, Tiniakos D, Burt A, et al. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? Gut. 2022;71(2):382\u2013390. https:\/\/doi.org\/10.1136\/gutjnl-2020-322564","journal-title":"Gut"},{"key":"10512_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7120562","author":"L Denkmayr","year":"2018","unstructured":"Denkmayr L, Feldman A, Stechemesser L, Eder SK, Zandanell S, Schranz M, et al. Lean patients with non-alcoholic fatty liver disease have a severe histological phenotype similar to obese patients. J Clin Med. 2018. https:\/\/doi.org\/10.3390\/jcm7120562","journal-title":"J Clin Med"},{"issue":"1","key":"10512_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep4.1124","volume":"2","author":"H Hagstr\u00f6m","year":"2018","unstructured":"Hagstr\u00f6m H, Nasr P, Ekstedt M, Hammar U, St\u00e5l P, Hultcrantz R, et al. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study. Hepatol Commun. 2018;2(1):48\u201357. https:\/\/doi.org\/10.1002\/hep4.1124","journal-title":"Hepatol Commun"},{"issue":"1","key":"10512_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2337\/cd18-0026","volume":"37","author":"P Golabi","year":"2019","unstructured":"Golabi P, Paik J, Fukui N, Locklear CT, de Avilla L, Younossi ZM. Patients with lean nonalcoholic fatty liver disease are metabolically abnormal and have a higher risk for mortality. Clin Diabetes. 2019;37(1):65\u201372. https:\/\/doi.org\/10.2337\/cd18-0026","journal-title":"Clin Diabetes"},{"issue":"1","key":"10512_CR38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13148-020-00917-2","volume":"12","author":"D Buzova","year":"2020","unstructured":"Buzova D, Maugeri A, Liguori A, Napodano C, Lo Re O, Oben J, et al. Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD). Clin Epigenetics. 2020;12(1):126. https:\/\/doi.org\/10.1186\/s13148-020-00917-2","journal-title":"Clin Epigenetics"},{"key":"10512_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.06.042","author":"W Sohn","year":"2021","unstructured":"Sohn W, Kwon HJ, Chang Y, Ryu S, Cho YK. Liver fibrosis in Asians with metabolic dysfunction-associated fatty liver disease. Clin Gastroenterol Hepatol. 2021. https:\/\/doi.org\/10.1016\/j.cgh.2021.06.042","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10512_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324162","author":"S Francque","year":"2021","unstructured":"Francque S, Wong VW. NAFLD in lean individuals: not a benign disease. Gut. 2021. https:\/\/doi.org\/10.1136\/gutjnl-2021-324162","journal-title":"Gut"},{"key":"10512_CR41","doi-asserted-by":"publisher","first-page":"155246","DOI":"10.1016\/j.metabol.2022.155246","volume":"134","author":"L Valenzuela-Vallejo","year":"2022","unstructured":"Valenzuela-Vallejo L, Mantzoros CS. Time to transition from a negative nomenclature describing what NAFLD is not, to a novel, pathophysiology-based, umbrella classification of fatty liver disease (FLD). Metabolism. 2022;134:155246. https:\/\/doi.org\/10.1016\/j.metabol.2022.155246","journal-title":"Metabolism"},{"issue":"1","key":"10512_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1148\/radiol.2019190467","volume":"294","author":"Z Guo","year":"2020","unstructured":"Guo Z, Blake GM, Li K, Liang W, Zhang W, Zhang Y, et al. Liver fat content measurement with quantitative CT validated against MRI proton density fat fraction: a prospective study of 400 healthy volunteers. Radiology. 2020;294(1):89\u201397. https:\/\/doi.org\/10.1148\/radiol.2019190467","journal-title":"Radiology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10512-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-023-10512-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10512-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T07:17:59Z","timestamp":1685171879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-023-10512-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10512"],"URL":"https:\/\/doi.org\/10.1007\/s12072-023-10512-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"assertion":[{"value":"28 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors (Hong Fan, Zhenqiu Liu, Pengyan Zhang, Sheng Wu, Xinyu Han, Yiwen Huang, Yichen Zhu, Xingdong Chen, Tiejun Zhang) disclose no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}